These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 33159646)

  • 1. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
    Hariharan A; Hakeem AR; Radhakrishnan S; Reddy MS; Rela M
    Inflammopharmacology; 2021 Feb; 29(1):91-100. PubMed ID: 33159646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.
    Attiq A; Yao LJ; Afzal S; Khan MA
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108255. PubMed ID: 34688149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.
    Elnosary ME; Shreadah MA; Ashour ML; Nabil-Adam A
    Int Immunopharmacol; 2024 Jan; 126():111072. PubMed ID: 38006751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms.
    Sanghai N; Tranmer GK
    Drug Discov Today; 2020 Dec; 25(12):2076-2079. PubMed ID: 32949526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydrozingerone ameliorates Lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the MAPK/NF-κB pathway.
    Tirunavalli SK; Gourishetti K; Kotipalli RSS; Kuncha M; Kathirvel M; Kaur R; Jerald MK; Sistla R; Andugulapati SB
    Phytomedicine; 2021 Nov; 92():153729. PubMed ID: 34517257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality.
    Que Y; Hu C; Wan K; Hu P; Wang R; Luo J; Li T; Ping R; Hu Q; Sun Y; Wu X; Tu L; Du Y; Chang C; Xu G
    Int Rev Immunol; 2022; 41(2):217-230. PubMed ID: 33616462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.
    Kircheis R; Haasbach E; Lueftenegger D; Heyken WT; Ocker M; Planz O
    Front Immunol; 2020; 11():598444. PubMed ID: 33362782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors.
    Kandasamy M
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):561-567. PubMed ID: 33394134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.
    Carcaterra M; Caruso C
    Med Hypotheses; 2021 Jan; 146():110412. PubMed ID: 33308936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review.
    Peddapalli A; Gehani M; Kalle AM; Peddapalli SR; Peter AE; Sharad S
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33673529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α.
    Moasefi N; Fouladi M; Norooznezhad AH; Yarani R; Rahmani A; Mansouri K
    Inflamm Res; 2021 Jul; 70(7):749-752. PubMed ID: 34173853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
    Root-Bernstein R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
    Gangemi S; Tonacci A
    Cytokine Growth Factor Rev; 2021 Apr; 58():111-113. PubMed ID: 32938545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.
    Sahebnasagh A; Mojtahedzadeh M; Najmeddin F; Najafi A; Safdari M; Rezai Ghaleno H; Habtemariam S; Berindan-Neagoe I; Nabavi SM
    Arch Med Res; 2020 Oct; 51(7):631-635. PubMed ID: 32863034
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Mardi A; Meidaninikjeh S; Nikfarjam S; Majidi Zolbanin N; Jafari R
    Viral Immunol; 2021 Dec; 34(10):679-688. PubMed ID: 34882013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2.
    Zheng J; Miao J; Guo R; Guo J; Fan Z; Kong X; Gao R; Yang L
    Front Cell Infect Microbiol; 2022; 12():931061. PubMed ID: 35774402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reactivity during COVID-19: Implications for treatment.
    Napoli C; Benincasa G; Criscuolo C; Faenza M; Liberato C; Rusciano M
    Immunol Lett; 2021 Mar; 231():28-34. PubMed ID: 33421440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.
    Su CM; Wang L; Yoo D
    Sci Rep; 2021 Jun; 11(1):13464. PubMed ID: 34188167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
    Sukhdeo S; Negroponte E; Rajasekhar H; Gaur S; Horton DB; Malhotra A; Moorthy LN
    Lupus; 2021 Apr; 30(5):836-839. PubMed ID: 33509065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.